AP4S1 splice-site mutation in a case of spastic paraplegia type 52 with polymicrogyria
Citation Manager Formats
Make Comment
See Comments

Hereditary spastic paraplegias (HSPs) are a group of rare inherited neurodegenerative disorders that result from primary retrograde dysfunction of the long descending fibers of the corticospinal tract, causing lower limb spasticity and muscular weakness. This group of diseases has a heterogeneous clinical presentation. An extensive list of associated genes, different inheritance patterns, and ages at onset have been reported in HSPs.1 Spastic paraplegia type 52 (SPG52) is an autosomal recessive disease caused by AP4S1 mutations. The disease is characterized by neonatal hypotonia that progresses to hypertonia and spasticity in early childhood, developmental delay, mental retardation, and poor or absent speech. Febrile or afebrile seizures may also occur.2,–,4
Clinical case presentation
We report the case of a Portuguese 2-year-old boy born to healthy nonconsanguineous parents after a full-term gestation with intrauterine growth restriction after week 37. During the first months of life, the patient presented poor weight gain, hyperammonemia with elevation of glutamine and ornithine, low citrulline, and negative orotic acid. Weight recovery and normalization of amino acid profile were observed after protein restriction and remained normal after reintroduction of normal diet. Genetic study of urea cycle disorders (NAGS, CPS, and OTC) was negative. Around 9 months of age, global developmental delay, hypotonia, and strabismus were evident. Brain MRI with spectroscopy (performed at 10 months) showed delayed myelination/hypomyelination associated with a posterior perisylvian polymicrogyria, thinning of the corpus callosum, dilation and dysmorphia of the ventricles, and enlargement of the subarachnoid frontotemporal space (figure A). Spectroscopy suggested a possible discrete reduction of N-acetylaspartate. EEG showed a slight intermittent lentification in the left temporal region. At 15 months of age, the patient had 1 afebrile episode of status epilepticus. Two previous shorter episodes with fever had also occurred. Levetiracetam was started. No regression of psychomotor development after seizure was observed, and the patient has been evolving gradually with improvement of axial hypotonia. He says a few simple words, responds to his name, and has some nonverbal communication. The most recent neurologic evaluation revealed an alteration of the muscle tone (hypertonia) in the left lower limb and pyramidal signs in both legs.
(A) Left image: sagittal T1 weighted image showing thin corpus callosum. Central and right images: axial T2 weighted images showing delayed myelination, bilateral posterior perisylvian polymicrogyria, dysmorphic and enlarged ventricles, and enlargement of subarachnoid space. (B) Family pedigree. The proband presents the splice-site variant chr14:g.31542180G>T NM_001128126.2:c.294+1G>T in the homozygous state, and both parents are heterozygous for the variant. +: c.294+1G>T allele; −: wild-type allele. (C) AP4S1 transcript size of the homozygous patient, both heterozygous parents, and the wild-type individual. A shorter transcript is produced in the presence of the variant. Each band of the marker ladder represents 100 bp (band size from gel bottom to top: 100, 200, 300, 400, 500, 600, 700, 800, 900, and 1000 bp). (D) Alignment of the wild-type protein sequence (NP_001121598) to the mutated protein. The alignment was performed with Clustal Omega. The variant leads to the loss of amino acids 76–98. C− = negative control; F = father; M = marker ladder; Mo = mother; mut = mutated protein; P = patient; WT = wild-type.
Exome sequencing of the proband and parents was performed as described in Supplementary Material (links.lww.com/NXG/A86) and revealed the homozygous AP4S1 splice site NM_001128126.2:c.294+1G>T r.619_687del variant in the proband, present in the heterozygous state in the parents (figure B). The variant was located in a 2.4-Mb homozygous region of chromosome 14. This variant is extremely rare in the population, with only 1 heterozygous individual present in the Genome Aggregation Database. In silico analysis predicted the loss of the donor splice site of exon 4. A transcript size analysis and Sanger sequencing of cDNA confirmed the presence of a shorter transcript skipping exon 4 associated with the variant (figure C). As a consequence, the polypeptide of 23 amino acids (76 a.a.–98 a.a.) encoded by exon 4 is lost (figure D).
Discussion
AP4S1 encodes the small subunit of the adaptor protein complex-4 (AP4 complex). This complex is recruited to the trans-Golgi network, where it mediates vesicle trafficking to endosomes or basolateral plasma membrane in a clathrin-independent manner.5 Mutations in the 4 subunits of the complex have been associated with similar autosomal recessive phenotypes mainly characterized by spastic tetraplegia.6 The mutation found in our patient leads to the loss of exon 4, with predicted important consequences to the protein structure and the AP4 complex function. Anatomical changes similar to those observed in patients have been reported in an AP-4 complex knockout mouse model: enlargement of the lateral ventricles and thinning of the corpus callosum.7 Similar changes have also been seen in the patient described here, together with febrile and afebrile seizures. When exome sequencing was performed and analyzed, the patient did not show hypertonia in the lower limbs. However, as reported in other patients, this clinical entity may progress from hypotonic to hypertonic status. The most recent neurologic evaluation revealed the presence of hypertonia in the left leg, associated with pyramidal signs, suggesting the possibility of future development of a spastic paraparesis, typical of this disease.
Here, we report a case of SPG52 associated with posterior perisylvian polymicrogyria, unexplained transitory hyperammonemia, and absence of facial dysmorphisms, which suggest an expansion of the disease phenotype.
Author contributions
S. Carmona: study concept and design; acquisition, analysis and interpretation of data; and writing of the manuscript. C. Marecos, M. Amorim, A.C. Ferreira, and C. Conceição: acquisition of patient data and critical revision of the manuscript for intellectual content. J. Brás: study concept and design; analysis and interpretation of data; and critical revision of the manuscript for intellectual content. S.T. Duarte: acquisition of patient data; analysis and interpretation of data; and writing and critical revision of the manuscript for intellectual content. R. Guerreiro: study concept and design; analysis and interpretation of data; study supervision; and writing and critical revision of the manuscript for important intellectual content.
Study funding
This work was partially funded by the Alzheimer's Society.
Disclosure
S. Carmona, C. Marecos, M. Amorim, A.C. Ferreira, and C. Conceição report no disclosures. J. Brás serves on the editorial board of the Journal of Parkinson's Disease and has received research support from the Alzheimer's Society. S. Temudo Duarte has received travel funding from Nutricia. R. Guerreiro serves on the editorial boards of ScienceMatters, the American Journal of Neurodegenerative Disease, and the Journal of Parkinson's Disease and has received research support from the Alzheimer's Society. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NG.
Acknowledgment
The authors acknowledge the family who participated in this study.
Footnotes
↵* These authors contributed equally to the manuscript.
Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NG.
The Article Processing charge was funded by the authors.
- Received February 20, 2018.
- Accepted in final form July 31, 2018.
- Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
References
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- Tessa A,
- Battini R,
- Rubegni A, et al
- 5.↵
- Park SY,
- Guo X
- 6.↵
- 7.↵
- Ivankovic D,
- López-Doménech G,
- Drew J,
- Tooze SA
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Babak Hooshmand and Dr. David Smith
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Articles
Bilateral generalized polymicrogyria (BGP)A distinct syndrome of cortical malformationB. S. Chang, X. Piao, C. Giannini et al.Neurology, May 24, 2004 -
Articles
Bilateral frontal polymicrogyriaA newly recognized brain malformation syndromeRenzo Guerrini, A. James Barkovich, László Sztriha et al.Neurology, February 22, 2000 -
Article
Speech, Language, and Oromotor Skills in Patients With PolymicrogyriaRuth O. Braden, Jessica O. Boyce, Chloe A. Stutterd et al.Neurology, February 15, 2021 -
Article
Blended Phenotype of Silver-Russell Syndrome and SPG50 Caused by Maternal Isodisomy of Chromosome 7Marvin Ziegler, Bianca E. Russell, Kathrin Eberhardt et al.Neurology: Genetics, December 29, 2020